BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 22455789)

  • 1. Synthesis and evaluation of analogues of estrone-3-O-sulfamate as potent steroid sulfatase inhibitors.
    Lawrence Woo LW; Leblond B; Purohit A; Potter BV
    Bioorg Med Chem; 2012 Apr; 20(8):2506-19. PubMed ID: 22455789
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Steroidal and nonsteroidal sulfamates as potent inhibitors of steroid sulfatase.
    Woo LW; Howarth NM; Purohit A; Hejaz HA; Reed MJ; Potter BV
    J Med Chem; 1998 Mar; 41(7):1068-83. PubMed ID: 9544207
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 2-difluoromethyloestrone 3-O-sulphamate, a highly potent steroid sulphatase inhibitor.
    Reed JE; Woo LW; Robinson JJ; Leblond B; Leese MP; Purohit A; Reed MJ; Potter BV
    Biochem Biophys Res Commun; 2004 Apr; 317(1):169-75. PubMed ID: 15047163
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and biological activity of the superestrogen (E)-17-oximino-3-O-sulfamoyl-1,3,5(10)-estratriene: x-ray crystal structure of (E)-17-oximino-3-hydroxy-1,3,5(10)-estratriene.
    Hejaz HA; Purohit A; Mahon MF; Reed MJ; Potter BV
    J Med Chem; 1999 Aug; 42(16):3188-92. PubMed ID: 10447965
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of novel steroid sulfatase inhibitors. I. Synthesis and biological evaluation of biphenyl-4-O-sulfamates.
    Okada M; Nakagawa T; Iwashita S; Takegawa S; Fujii T; Koizumi N
    J Steroid Biochem Mol Biol; 2003 Nov; 87(2-3):141-8. PubMed ID: 14672734
    [TBL] [Abstract][Full Text] [Related]  

  • 6. D-ring modified estrone derivatives as novel potent inhibitors of steroid sulfatase.
    Fischer DS; Woo LW; Mahon MF; Purohit A; Reed MJ; Potter BV
    Bioorg Med Chem; 2003 Apr; 11(8):1685-700. PubMed ID: 12659755
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of steroid sulfatase with 4-substituted estrone and estradiol derivatives.
    Phan CM; Liu Y; Kim BM; Mostafa Y; Taylor SD
    Bioorg Med Chem; 2011 Oct; 19(20):5999-6005. PubMed ID: 21925885
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estrogen O-sulfamates and their analogues: Clinical steroid sulfatase inhibitors with broad potential.
    Thomas MP; Potter BV
    J Steroid Biochem Mol Biol; 2015 Sep; 153():160-9. PubMed ID: 25843211
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estrone formate: a novel type of irreversible inhibitor of human steroid sulfatase.
    Schreiner EP; Billich A
    Bioorg Med Chem Lett; 2004 Oct; 14(19):4999-5002. PubMed ID: 15341968
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potent inhibition of steroid sulfatase activity by 3-O-sulfamate 17alpha-benzyl(or 4'-tert-butylbenzyl)estra-1,3,5(10)-trienes: combination of two substituents at positions C3 and c17alpha of estradiol.
    Ciobanu LC; Boivin RP; Luu-The V; Labrie F; Poirier D
    J Med Chem; 1999 Jun; 42(12):2280-6. PubMed ID: 10377235
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis, in vitro and in vivo activity of benzophenone-based inhibitors of steroid sulfatase.
    Hejaz HA; Woo LW; Purohit A; Reed MJ; Potter BV
    Bioorg Med Chem; 2004 May; 12(10):2759-72. PubMed ID: 15110857
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of estrone sulfatase by aromatase inhibitor-based estrogen 3-sulfamates.
    Numazawa M; Tominaga T; Watari Y; Tada Y
    Steroids; 2006 May; 71(5):371-9. PubMed ID: 16476457
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Boronic acids as inhibitors of steroid sulfatase.
    Ahmed V; Liu Y; Silvestro C; Taylor SD
    Bioorg Med Chem; 2006 Dec; 14(24):8564-73. PubMed ID: 16973364
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inactivation of steroid sulfatase by an active site-directed inhibitor, estrone-3-O-sulfamate.
    Purohit A; Williams GJ; Howarth NM; Potter BV; Reed MJ
    Biochemistry; 1995 Sep; 34(36):11508-14. PubMed ID: 7547880
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The development of A-ring modified analogues of oestrone-3-O-sulphamate as potent steroid sulphatase inhibitors with reduced oestrogenicity.
    Purohit A; Vernon KA; Hummelinck AE; Woo LW; Hejaz HA; Potter BV; Reed MJ
    J Steroid Biochem Mol Biol; 1998 Mar; 64(5-6):269-75. PubMed ID: 9618028
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 2-phenylindole sulfamates: inhibitors of steroid sulfatase with antiproliferative activity in MCF-7 breast cancer cells.
    Walter G; Liebl R; von Angerer E
    J Steroid Biochem Mol Biol; 2004 Apr; 88(4-5):409-20. PubMed ID: 15145451
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of steroid sulfatase inhibitors.
    Woo LW; Purohit A; Potter BV
    Mol Cell Endocrinol; 2011 Jul; 340(2):175-85. PubMed ID: 21238537
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Solid-phase parallel synthesis of 17alpha-substituted estradiol sulfamate and phenol libraries using the multidetachable sulfamate linker.
    Ciobanu LC; Poirier D
    J Comb Chem; 2003; 5(4):429-40. PubMed ID: 12857111
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 17β-Arylsulfonamides of 17β-aminoestra-1,3,5(10)-trien-3-ol as highly potent inhibitors of steroid sulfatase.
    Mostafa YA; Taylor SD
    Bioorg Med Chem; 2012 Feb; 20(4):1535-44. PubMed ID: 22264754
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The design, synthesis, and biochemical evaluation of derivatives of biphenyl sulfamate-based compounds as novel inhibitors of estrone sulfatase.
    Ahmed S; James K; Owen CP
    Biochem Biophys Res Commun; 2002 May; 294(1):180-3. PubMed ID: 12054760
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.